Aris N. Economides

6 Patents

• US124735742025

  Methods for Modifying a Genome

  REGENERON PHARMACEUTICALS, Inc.

  0 cites
• US120895762024

  Nucleic Acids Comprising a Modified Rodent Activin a Receptor Type 1 (acvr1) Gene

  Regeneron Pharmaceuticals, Inc.

  0 cites
• US119458722024

  Anti-acvr1 Antibodies and Uses Thereof

  Regeneron Pharmaceuticals, Inc.

  0 cites
• US117301502023

  Fibrillin-1 Mutations for Modeling Neonatal Progeroid Syndrome with Congenital Lipodystrophy

  Regeneron Pharmaceuticals, Inc.

  0 cites
• US116344802023

  Human Antibodies to GREM1

  Regeneron Pharmaceuticals, Inc.

  0 cites
• US115781352023

  Multispecific Antigen-binding Molecules Binding to a Target and an Internalizing Effector Protein That Is CD63 and Uses Thereof

  Regeneron Pharmaceuticals, Inc.

  0 cites